type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 12/10/2025 | 12/11/2025 | 0.02000000 |
| Dividends | 12/11/2024 | 12/12/2024 | 0.72827000 |
| Dividends | 12/14/2023 | 12/15/2023 | 0.14900000 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| RVMD | Stock | Healthcare | US$ 45.01 B | 6,07% | |
| LLY | Stock | Healthcare | US$ 1.02 T | 5,20% | |
Cogent Biosciences Inc
|
UMRX | Stock | Healthcare | US$ 73.23 M | 4,74% |
Roche Holding Ltd ADR
|
RHHBY | Stock | Healthcare | US$ 343.12 B | 4,21% |
| NOVN | Stock | Healthcare | US$ 246.29 B | 3,82% | |
| BMY | Stock | Healthcare | US$ 136.49 B | 3,60% | |
| MRK | Stock | Healthcare | US$ 370.89 B | 3,59% | |
| ABBV | Stock | Healthcare | US$ 459.82 B | 3,35% | |
| HALO | Stock | Healthcare | US$ 12.51 B | 3,21% | |
| BGNE | Stock | Healthcare | US$ 20.21 B | 3,21% | |
| JNJ | Stock | Healthcare | US$ 663.28 B | 3,12% | |
| IMNM | Stock | Healthcare | US$ 3.08 B | 3,02% | |
| GMAB | Stock | Healthcare | US$ 133.07 B | 2,90% | |
CG Oncology, Inc. Common stock
|
CGON | Stock | Healthcare | US$ 6.62 B | 2,78% |
| IDYA | Stock | Healthcare | US$ 3.85 B | 2,73% | |
| EXEL | Stock | Healthcare | US$ 14.62 B | 2,65% | |
| BBIO | Stock | Healthcare | US$ 14.63 B | 2,35% | |
| AMGN | Stock | Healthcare | US$ 240.11 B | 2,07% | |
Enliven Therapeutics Inc.
|
ELVN | Stock | Healthcare | US$ 4.35 B | 2,06% |
| AZN | Stock | Healthcare | US$ 186.20 B | 2,01% | |
| LEGN | Stock | Healthcare | US$ 4.23 B | 1,97% | |
| ZLAB | Stock | Healthcare | US$ 2.89 B | 1,96% | |
| CELC | Stock | Healthcare | US$ 4.72 B | 1,82% | |
Erasca Inc
|
ERAS | Stock | Healthcare | US$ 5.69 B | 1,78% |
| RLAY | Stock | Healthcare | US$ 4.06 B | 1,63% | |
| IOVA | Stock | Healthcare | US$ 3.94 B | 1,58% | |
|
ZYMEWORKS DL-00001
|
ZA8 | Stock | Healthcare | US$ 1.77 B | 1,55% |
| NUVB | Stock | Healthcare | US$ 2.38 B | 1,33% | |
| URGN | Stock | Healthcare | US$ 2.19 B | 1,26% | |
Arcus Biosciences Inc
|
RCUS | Stock | Healthcare | US$ 3.73 B | 1,22% |
| KURA | Stock | Healthcare | US$ 1.17 B | 1,04% | |
| GILD | Stock | Healthcare | US$ 187.51 B | 1,02% | |
|
TYRA
|
TYRA_old | Stock | Healthcare | US$ 903.02 M | 1,02% |
| SMMT | Stock | Healthcare | US$ 13.67 B | 0,98% | |
| CRVS | Stock | Healthcare | US$ 1.23 B | 0,96% | |
| NTRA | Stock | Healthcare | US$ 47.23 B | 0,94% | |
| BCTG | Stock | Financial | US$ 218.05 M | 0,89% | |
| ANAB | Stock | Healthcare | US$ 1.70 B | 0,89% | |
| IMTX | Stock | Healthcare | US$ 1.46 B | 0,82% | |
| REPL | Stock | Healthcare | US$ 1.42 B | 0,79% | |
| IMCR | Stock | Healthcare | US$ 1.93 B | 0,78% | |
| CGEM | Stock | Healthcare | US$ 1.34 B | 0,69% | |
| GH | Stock | Healthcare | US$ 21.66 B | 0,67% | |
| ORIC | Stock | Healthcare | US$ 1.32 B | 0,61% | |
| CADL | Stock | Healthcare | US$ 992.45 M | 0,54% | |
| SNDX | Stock | Healthcare | US$ 1.85 B | 0,51% | |
Janux Therapeutics Inc
|
JANX | Stock | Healthcare | US$ 1.21 B | 0,47% |
| INBX | Stock | Healthcare | US$ 1.80 B | 0,43% | |
|
BridgeBio Oncology Therapeutics, Inc.
|
BBOT | Stock | Healthcare | US$ 727.98 M | 0,42% |
| OLMA | Stock | Healthcare | US$ 938.85 M | 0,42% | |
Bicara Therapeutics Inc. Common Stock
|
BCAX | Stock | Healthcare | US$ 1.53 B | 0,41% |
Average Investor10 user rating
4.0
(21 people)
Tema Oncology ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $205.78 million.
Over the past 12 months, Tema Oncology ETF recorded a return of 52.36%, with its price trading between $26.74 and $45.24 during the same period.
The ETF is traded under the ticker CANC.
The current price of CANC is $41.63. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
CANC is currently trading at $41.63, with a market capitalization of approximately $205.776.650,00. Over the past year, the ETF has delivered a 52.36% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in CANC through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol CANC, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, CANC has returned -6.64%, and 52.36% over the past year.
If you were to purchase 100 shares of CANC at the current price of $41.63, your total investment would be $4,163.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
